Latest Coronavirus News By Robin Foster HealthDay Reporter THURSDAY, Feb. 25, 2021 (HealthDay News) If you think you can safely exercise without your mask in a gym during the pandemic, two new government reports show you are mistaken. Coronavirus outbreaks at fitness centers in Chicago and Honolulu last summer were likely the result of exercisers
Latest Allergies News By Alan Mozes HealthDay Reporter THURSDAY, Feb. 25, 2021 (HealthDay News) If you suffer the itchy, sneezy, wheezy consequences of seasonal allergies, you’re probably painfully aware that pollen season is starting earlier and lasting longer than ever. It’s an upshot of climate change, and new research from Germany offers an explanation for
Latest Alzheimer’s News By Steven Reinberg HealthDay Reporter FRIDAY, Feb. 26, 2021 The ravages of Alzheimer’s may strike later in women than men, but once it takes hold women tend to deteriorate far faster than men, according to a new study. Something known as cognitive reserve helps the aging brain function better for longer, and
Latest Diet & Weight Management News By Colin Tweedy HealthDay Reporter THURSDAY, Feb. 25, 2021 (HealthDay News) Helping your brain stay sharp with age may be as simple as changing up the food on your plate at dinnertime, a new study suggests. The study focused on the healthy “Mediterranean” diet, a regimen reliant on olive
The U.S. FDA’s January approval of Abbott’s hand-held blood plasma test for mild traumatic brain injury is “an important first step” in enabling quick quantified analysis of suspected concussions without waiting for imaging to be done and read—and also a vital exemplar of a public/private research and development TBI ecosystem that has matured and coalesced
Former SAIS Dean and current Majid Khadduri Professor of International Affairs and Middle East Studies, Vali Nasr joins Immigrant Food partners and SAIS alums Peter Schechter and Téa Ivanovic in a wide-ranging conversation about the growing role of business in social justice and advocacy, the challenges of accelerating global migration, and recent events in the
Startups are the lifeblood of the medical device industry because they have the ability to pull off big feats and innovate more nimbly than the larger players. That said, there is a lot of medtech engineering challenges that startups should be aware of. In this episode of Let’s Talk Medtech, Dan Purvis, CEO and co-founder
Otsuka Pharmaceutical and Click Therapeutics are making their major depressive disorder (MDD) clinical trial ‘remote’ and are working with Verily Life Sciences to do so. The pivotal trial will investigate the effectiveness of digital therapeutics in reducing depressive symptoms in up to 540 adults diagnosed with MDD who are on antidepressant monotherapy. The participation will
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published
The twinkle in his eyes, the delight in his smile, the joyous way he moved his disease-withered frame. They all proclaimed a single, resounding message: Grateful to be alive! “As my care team and my family tell me, ‘You were born again. You have to learn to live again,'” said Vicente Perez Castro. “I went
Latest Coronavirus News By Alan Mozes HealthDay Reporter THURSDAY, Feb. 25, 2021 Hungry for good news on the pandemic? One epidemiologist believes Americans might reach herd immunity to the new coronavirus as soon as late spring. That’s the view held by Suzanne Judd, a professor with the school of public health at the University of
Latest Coronavirus News WEDNESDAY, Feb. 24, 2021 (HealthDay News) Protective immune system antibodies that develop after being infected with COVID-19 last for at least a few months, a new study suggests. And reinfection does seem to be relatively rare. That could have big implications for public health and societies, including allowing people to return to
Porvair Sciences Krystal™ Glass Bottom microplate with Schott D 263® M technology provides unmatched performance for whole-plate CCD imaging and laser detection applications Krystal™ Glass Bottom plates combine the advantageous optical properties of glass, low background and low birefringence, with the versatility of a microplate. Constructed in ultra-pure grade borosilicate glass – the new D
Latest Coronavirus News By Dennis Thompson HealthDay Reporter WEDNESDAY, Feb. 24, 2021 (HealthDay News) Need a COVID-19 vaccine? Your neighborhood pharmacy may soon have one on hand. Pharmacies across the United States are joining the coronavirus vaccination effort, as part of the Biden administration’s push to reach herd immunity as quickly as possible in this
From the beginning, Hims & Hers CEO Andrew Dudum had imagined he would take his startup public through a traditional IPO. But last month, the direct-to-consumer health startup ended up taking a different route. The startup merged with a special-purpose acquisition company formed by Oaktree Capital Management, effectively a shell company that goes public with
A new comprehensive course incorporating an interdisciplinary approach to disaster preparedness shows promise for better equipping health professionals in responding to disasters. Medical staff and researchers from Tohoku University and Fukushima Medical University organized the program. The two universities are well equipped in disaster response and preparedness given their regions were at the epicenter of
NuVasive add a differentiated cervical disc to its product portfolio through a $150 million acquisition of Simplify Medical. Simpify Medical developed the Simplify cervical artificial disc, or Simplify Disc, for cervical total disc Replacement (cTDR). While NuVasive has had a cervical disc that launched in 2012, its offering never gained much traction in the market place. The
Researchers at the Indian Institute of Science and SigTuple Technologies, a company based in Bengaluru, India, have developed a method to inexpensively measure hemoglobin levels in small-volume blood samples. The technique combines a microfluidic chip and an AI-powered microscope. The researchers hope that the technology will help streamline hemoglobin measurements and make things easier for
In acquiring new medical technologies, the patent rights to that technology often drive the value of the transaction. An evaluation of the commercial product is all well and good, but much of the value arises from exclusive rights to market the technology. After all, the purchasing company will likely be obliged to invest in that
The performing arts industry has been thoroughly upended by the COVID-19 pandemic, with venues shut down, performances canceled, and artists out of work. A Brookings Institution report issued last summer estimated the damage in the fine and performing arts at almost 1.4 million jobs and $42.5 billion in sales lost. On February 10, the Peabody